Citation Impact
Citing Papers
Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson´s disease patients with motor complications
2010
Practice Parameter: Treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): [RETIRED]
2006
The clinical symptoms of Parkinson's disease
2016 Standout
Exercise and Mental Health: Many Reasons to Move
2009
Criteria for assessing the tools of disability outcomes research
2000 Standout
Systematic evaluation of rating scales for impairment and disability in Parkinson's disease
2002
Glutamate receptor ion channels
2005 Standout
Non-motor symptoms of Parkinson's disease: diagnosis and management
2006 Standout
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Exercise to prevent and treat functional disability
2002
Parkinson disease
2017 Standout
The Anticonvulsant Lamotrigine in Treatment-Resistant Manic-Depressive Illness
1997
Functional changes of the basal ganglia circuitry in Parkinson's disease
2000
A Review on Central Nervous System Effects of Gastrodin
2018 Standout
Genetic basis for individual variations in pain perception and the development of a chronic pain condition
2004 Standout
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
2009 Standout
Physical Benefits of Dancing for Healthy Older Adults: A Review
2009 Standout
Descending control of pain
2002 Standout
Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission A double-blind, comparative study
1998
Gene and Protein Expression Profiles of Anti‐ and Pro‐apoptotic Actions of Dopamine,R‐Apomorphine, Green Tea Polyphenol (−)‐Epigallocatechine‐3‐gallate, and Melatonin
2003
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
2017 Standout
Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
2020 Standout
How might physical activity benefit patients with Parkinson disease?
2011
Exercise Standards for Testing and Training
2013 Standout
Parkinson's disease: clinical features and diagnosis
2008 Standout
Orthostatic hypotension as an early finding in Parkinson’s disease
2006
Subthalamic nucleus deep brain stimulation: Summary and meta-analysis of outcomes
2006 Standout
The role of the basal ganglia in nociception and pain
1995
Drug-Induced Hepatotoxicity
2003 Standout
A Placebo-Controlled 18-Month Trial of Lamotrigine and Lithium Maintenance Treatment in Recently Manic or Hypomanic Patients With Bipolar I Disorder
2003 Standout
Donepezil in Parkinson's disease dementia: A randomized, double‐blind efficacy and safety study
2012
Patterns of Outcome Measurement in Parkinson’s Disease Clinical Trials
2000
In vivo imaging of synaptic function in the central nervous system
2009
Regulation of brain function by exercise
2003
The Beneficial Role of Intensive Exercise on Parkinson Disease Progression
2013
The role of executive function and attention in gait
2007 Standout
Health-related quality of life outcomes measures
2000
Canadian guideline for Parkinson disease
2019 Standout
Falls and freezing of gait in Parkinson's disease: A review of two interconnected, episodic phenomena
2004 Standout
Diagnostic criteria for multiple sclerosis
2001 Standout
Exercise Comes of Age: Rationale and Recommendations for a Geriatric Exercise Prescription
2002
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and α‐tocopherol
1997
Treatment of Cognitive, Psychiatric, and Affective Disorders Associated with Parkinson's Disease
2013
Exercise and aging
2004
Evidence‐Based Efficacy Comparison of Tolcapone and Entacapone as Adjunctive Therapy in Parkinson's Disease
2008
Changes in gait while backward counting in demented older adults with frontal lobe dysfunction
2007
Tolcapone and Hepatotoxic Effects
2000
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
2004 Standout
Green tea and its polyphenolic catechins: Medicinal uses in cancer and noncancer applications
2006 Standout
Caffeine (1, 3, 7‐trimethylxanthine) in Foods: A Comprehensive Review on Consumption, Functionality, Safety, and Regulatory Matters
2010 Standout
Motor fluctuations in Parkinson's disease: pathophysiology and treatment
1999
Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus
2002
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease
2004 Standout
Non-motor features of Parkinson disease
2017 Standout
The Neuroendocrinology of Stress: A Never Ending Story
2008 Standout
Systematic review of levodopa dose equivalency reporting in Parkinson's disease
2010 Standout
Subcutaneous Apomorphine
2004
Fatigue in Parkinson's disease: A review
2006
Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?
1997
Clinical Pharmacology, Therapeutic Use and Potential of COMT Inhibitors in Parkinson???s Disease
2000
Assessment and management of behavioral and psychological symptoms of dementia
2015 Standout
Unified Parkinson's disease rating scale characteristics and structure
1994
Exercise and Physical Activity for Older Adults
2009 Standout
Management of Parkinson's disease: An evidence-based review
2002
Comparison of the effects of a physiotherapist-supervised exercise programme and a self-supervised exercise programme on quality of life in patients with Parkinson’s disease
2010
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Gut microbiota are related to Parkinson's disease and clinical phenotype
2014 Standout
Evaluating non-randomised intervention studies
2003 Standout
Treatment of depression in Parkinson's disease: a meta-analysis
1995
Catechol-O-methyltransferase (COMT): Biochemistry, Molecular Biology, Pharmacology, and Clinical Efficacy of the New Selective COMT Inhibitors
1999
Orthostatic hypotension from sympathetic denervation in Parkinson’s disease
2002
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
Evidence-Based Efficacy Comparison of Tolcapone and Entacapone as Adjunctive Therapy in Parkinson's Disease
2008
A Historical Overview of Natural Products in Drug Discovery
2012 Standout
Physical Activity and Public Health in Older Adults
2007 Standout
Progressive resistance strength training for improving physical function in older adults
2009 Standout
Neurovascular Coupling in Parkinson's Disease Patients: Effects of Dementia and Acetylcholinesterase Inhibitor Treatment
2010
A Systematic Review of Newer Pharmacotherapies for Depression in Adults: Evidence Report Summary: Clinical Guideline, Part 2
2000 Standout
Works of H. Baas being referenced
Concentration-Effect Relationship of Levodopa in Patients with Parkinson's Disease
1995
Lamotrigine in Parkinson's disease — a double blind study
1995
Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patients
1997
The effect of exercise on pharmacokinetics and pharmacodynamics of levodopa
2000
Lamotrigine-antiparkinsonian activity by blockade of glutamate release?
1993
Therapeutic value of exercise training in Parkinson???s disease
1999
Quantification of IBZM dopamine receptor SPET in de novo Parkinson patients before and during therapy
1997
Scales in Parkinson’s disease
2006
Value and appropriate use of rating scales and apparative measurements in quantification of disability in Parkinson's disease
1993
[Orthostatic dysregulation in Parkinson syndrome. Results of a study of 250 patients].
1990
Mesulergine and bromocriptine in long-term treatment of advanced parkinsonism
1985
Therapeutic efficacy of R-(-)-deprenyl as adjuvant therapy in advanced parkinsonism.
1987
Efficacy and safety of tolcapone in levodopa‐treated Parkinson's disease patients with “wearing‐off” phenomenon: a multicentre, double‐blind, randomized, placebo‐controlled trial
1997
Catechol-O-methyltransferase inhibition with tolcapone reduces the"wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patients
1998
Pharmacodynamics of levodopa coadministered with apomorphine in parkinsonian patients with end-of-dose motor fluctuations.
1998
The DONPAD-study — Treatment of dementia in patients with Parkinson’s disease with donepezil
2006
Dose response and concentration response relationship of apomorphine in patients with Parkinson's disease and end-of-dose akinesia.
1998